StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.02−0.08 (-1.13%)

Close on Nov 17, 2026Market cap $254.77MP/E –Yield –

Evommune market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Evommune's market cap was $312.75M on Nov 11, 2026, against $32.20M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$312.75M+1074.8%
2025Dec 31, 2025$26.62M–

More Evommune figures

See a number that looks wrong?